These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Markers of chronic hepatitis B in children after completion of therapy with isoprinosine].
    Author: Kowalik-Mikołajewska B, Barszcz T, Ladyzyńska E, Wojnarowski M.
    Journal: Pol Tyg Lek; ; 48(11-13):263-4. PubMed ID: 7694263.
    Abstract:
    Fourteen children with chronic active hepatitis B treated with isoprinosine were followed-up for 3-8 years. In no child HBs antigen was eliminated. No seroconversion was noted in children in whom HBe antigen was eliminated. Anti-HBe antibodies were found in 11 children, including 6 children in whom they were present all the time following therapy, and 2 children in whom these antibodies reappeared after an initial elimination. These results suggest that the inhibition of hepatitis B virus replication produced by isoprinosine may be transient. Therefore, longer lasting immunomodulating therapy should be considered.
    [Abstract] [Full Text] [Related] [New Search]